Taking medication in diabetes self-management: Issues and recommendations for reducing barriers

Susan Cornell*, June M. Mckoy, Nancy Letassy, Linda Haas, Suzanne A. Boren, Karen A. Fitzner, Martha Quintana, Edwin B. Fisher, Kristina Ernst, Micki Hall, Jennifer D'Souza, Dawn Sherr

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

objectives: To advance self-management of diabetes by recognizing that many individuals with diabetes in the United States have not achieved glycemic control but diabetes self-management is effective in controlling the disease. study design: Expert panel discussion and review of the diabetes self-management, behavioral, and medication-taking literature. methods: Self-management attributes of diabetes education and barriers to medication taking were examined by a multidisciplinary panel that assembled at the American Association of Diabetes Educators (AADE) Taking Medication Symposium in September 2009. results: Multiple factors impede adherence; a link exists between poor medication adherence and worse outcomes. Patients need to be empowered and knowledgeable about each medication, including its action, side effects, efficacy, toxicity, prescribed dosage, appropriate timing, and frequency of administration. Diabetes education is instrumental in this. conclusions: Adherence to antihyperglycemic medication often is impeded by a variety of barriers. Lifelong diabetes self-management education is needed to help patients with taking medication as changes occur in their lives. Diabetes educators and other providers are urged to look at the patient as a whole, respecting the patient's right to make decisions and taking into consideration lifestyle factors that impact taking medication and other AADE7 behaviors. Clinicians also must recognize older patients as a unique population in diabetes. Diabetes educators and providers need to tap into community resources, because community workers often are privy to issues of nonadherence and other difficulties that a person with diabetes may be experiencing. New pharmacologic therapies and changes in dosing will drive the need for updated systematic reviews of the emerging literature.

Original languageEnglish (US)
Pages (from-to)263-271
Number of pages9
JournalAmerican Journal of Pharmacy Benefits
Volume3
Issue number5
StatePublished - Sep 1 2011

ASJC Scopus subject areas

  • Business and International Management
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Decision Sciences (miscellaneous)

Fingerprint Dive into the research topics of 'Taking medication in diabetes self-management: Issues and recommendations for reducing barriers'. Together they form a unique fingerprint.

Cite this